1 résultat
Study design and rationale for IFCT- 2203 TAXIO: A study that aims to evaluate the effectiveness of a first-line chemotherapy regimen without etoposide, combined with durvalumab, for patients with extensive disease small cell lung cancer
			Auteurs / Authors		
		
			Moro-Sibilot D, Falchero L, Ardin C, Zouak A, Molinier O, Romand P, Leleu O, Amrane K, Berndt C, Langlais A, Morin F, Westeel V		
	
			Journal / Conference		
		
			Respiratory  Medicine and Research 		
	
			Année / Year		
		
			2024		
	
			PMID / session		
		
	
				Etude IFCT			
			
		